Page 6 - Multiple Sclerosis Ms News Today

"The take-home finding is that herpes zoster incidence is high among people with MS overall."

A new study examined the prevalence of multiple sclerosis in different ethnic and racial groups and found that the disease is becoming more racially diverse.

"Doctors might perceive that the relationship is the same with all of their patients when their patients have a very different perception of what that relationship is and whether theyre not being heard."

Multiple treatment transitions in patients with NMOSD are associated with increased neurological harm, including increased relapse risk and disease progression.

Patients with rheumatoid arthritis who take a tumor necrosis factor inhibitor do not appear to have a consistent and significant risk for developing a demyelinating disease.

The use of the monoclonal antibody satralizumab for the long-term treatment of neuromyelitis optica spectrum disorder provides sustained freedom from relapse with no new safety concerns over 5 years.

Previous research has found that life stressors are linked to clinical MS flares.

Autologous stem cell transplant reduced the risk for relapses, compared with fingolimod and natalizumab, in a recent analysis.

Novel S1P1 receptor modulator cenerimod shows impact on disease activity in lupus, with more pronounced benefits in those with more severe disease.

Expanded labeling applies to MR condition leads, allowing for higher quality scan images for patients with chronic pain.